39P AntiEGFR-based maintenance versus stop&go strategy in patients with left-sided, non MSI, RAS/BRAF wild type (wt) metastatic colorectal cancer (mCRC): Individual patient data (IPD) pooled analysis of randomized clinical trials (RCTs)
Title:
39P AntiEGFR-based maintenance versus stop&go strategy in patients with left-sided, non MSI, RAS/BRAF wild type (wt) metastatic colorectal cancer (mCRC): Individual patient data (IPD) pooled analysis of randomized clinical trials (RCTs)
Author:
Raimondi, A. Tinè, G. De Stefano, A. Ballhausen, A. Bouche, O. Morano, F. Stahler, A. Romano, C. Prisciandaro, M. Randon, G. Gourgou, S. Alig, A.H.S. Cassata, A. Fazio, R. Brument, E. Miceli, R. Boige, V. Avallone, A. Modest, D.P. Pietrantonio, F.